Member Info for itsallamess

Heading back up..

1 share trade on the naz... RNS incoming?

Good question.

You can see on this site the trades on the naz market.

You can see when large sells, comparing with what's being bought of AIM.. it matches.

Plus since the naz listing was formed we have seen the constant 5000 buys on aim

http://www.nasdaqomxnordic.com/aktier/microsite?Instrument=HEX185076&name=Faron%20Pharmaceuticals%20Oy&ISIN=FI4000153309

I reckon the sellers are just impatient people who are moving on to other opportunities they feel will give a quicker return.

I held a few of GGP, bought at .8 and sold at 2.30, if I held... they are now 11.20!

Would of made loads if I was more patient.

The upside is I put my ggp money in farn at .80 which means I'm acually more in profit than just holding at ggp.

My point: make the right call you win. But you cant win them all at the same time unless you have infinite funds.

I'm holding and wont be selling any of my FARN shares.
This will rocket when all the good news that is due lands

Nice 10,000 share buy.
That could also be for the NAZ

At least 6 lots yesterday

Doesnt matter who sells on the AIM listing, everyday lago capital keeps siphoning lots of 5000 shares and supplying the nordic market.

Good for them I say,

For further information on the R&D Day, or to register for the event, please contact Consilium Strategic Communications at faron@consilium-comms.com or telephone +44 (0)20 3709 5700.

Still at it, if its lago buying for the naz market.. it's a contant feature now that AIM market free float is literally shrinking!

There was a different job advertised before remap was announced. I seem to remember it was something to do with supply of Traumakine? Anyone remember?

It's interesting that there are low rumblings of results coming out but nothing official

Seems to be more articles on interferon beta 1a

My guess I that the results will say it works at improving covid patients. Question will be which form of treatment works best.

Faron has IV paitented
There is also injection form.

Obviously faron has the research that says that IV formulation provides a better delivery and better results although it's more than just stick interferon in a IV dri

Merek pharma gave who alot more of their MS version of interferon beta 1a

Trying to think back a couple of months to the job position up for faron. Was it something to do with packaging, sales and distribution?

CB
Thanks matey

Test

What website are you using to check the Nasdaq trades?

Thanks faze

Not gonna buy any more.

I'm gonna just leave it and see what happens. Wrote it off when they suspended anyway.

Not gonna start paying money to average down I the hope to break even on this one.. typical AIM lock you in for life company

Before the suspension my shares where worth £1300,000 now £48,00

What's happening here?

We could see a manurfacting agreement made befor the R&D day

I see, of course, thanks colly

https://www.investegate.co.uk/article.aspx?id=202005260800058060N

This could be a posibility

Rebif is owned by Merck group a german company, we own the intellectual property and patent for the highly engineered designed delivery system of interferon beta 1a which marku says is the best way to treat ARDs

Could merck partner with us to develop trumakine as a covid symptom treatment?

Zum

It feels like a retaliation for the WHO is stop trials for Trumps drug
However it could also that it deosnt work.

Whatever the case the other ARMS are continuing to be tested which inc Interferon beta 1a

Now we know that the MS drug rebif which is interferon beta 1a has been included in the solidarity trials but so have we...

And Traumakine use of interferon beta 1a has been highly engenered/patent protected delivery system to treat ARDS

Our CEO has already said he keeps the claims low key cause he doesnt mess with investors like many other over hype companies but as far as I'm concerned Markku knows his stuff and quietly we could be making giant waves and when results are discussed on saturday according to WHO tweet we could be seeing good news about interferon beta 1a and trumakine